Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

Clinical trial NCT00660595 · TERMINATED

Trial details

NCT number: NCT00660595
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenic Disorders

Start date: 2008-09-01
Primary completion: 2008-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.